Capabilities

Mental Health Products ECHO ECHO combines pharmacovigilance and pharmacoepidemiological expertise with an experienced team of mental health specialists from across [...]

Risk Management Since 2012, the role of the Risk Management Plan (RMP) has gained huge importance, with the requirement that every new medicinal product [...]

Registries In the context of registries used for evaluating patient outcomes, a patient registry is defined as an organised system that uses observational study [...]

Systematic Reviews for Pharmacovigilance and Risk Management Often, individual studies are too small to provide a good picture of the [...]

Enhanced safety surveillance on seasonal flu vaccines Since the publication in April 2014 of EMA interim guidance detailing the requirement for enhanced [...]

Drug Utilisation Studies Drug utilisation studies examine the marketing, distribution, prescription and use of drugs in a society, with special [...]

PASS studies in primary care (MPEM) PASS studies in primary care (MPEM) The technique of Prescription-Event Monitoring (PEM) is a [...]

The DSRU Centre for Pharmacovigilance Methodology The Centre for Pharmacovigilance Methodology builds on the DSRU’s widely-quoted methodological research in pharmacovigilance [...]

European Network Studies Risk Management and Risk Minimisation studies conducted by a network of European countries The DSRU has experience [...]

PASS studies in secondary care (SCEM) One of our key capabilities is undertaking Post-authorisation Safety Studies (PASS) in the hospital [...]